A patient-aware benchmarking of CNN and transformer architectures for breast cancer histopathology classification - Scorecard - MDSpire

A patient-aware benchmarking of CNN and transformer architectures for breast cancer histopathology classification

  • By

  • Veeram Priyanka

  • Modigari Narendra

  • Tharasi Dilleswar Rao

  • May 8, 2026

  • 0 min

Share

Clinical Scorecard: Patient-Centric Evaluation of CNN and Transformer Models for Classifying Breast Cancer Histopathology Images

At a Glance

CategoryDetail
ConditionBreast Cancer Histopathology Classification
Key MechanismsDeep learning models including CNNs and transformers for image analysis.
Target PopulationPatients with breast cancer requiring histopathological diagnosis.
Care SettingClinical pathology laboratories.

Key Highlights

  • Nine deep learning architectures evaluated on the BreaKHis dataset.
  • Strict 5-fold patient-aware cross-validation protocol used.
  • ResNet50 achieved the highest mean accuracy (0.9267 ± 0.0435).
  • No statistically significant differences in performance among models.
  • Intermediate magnification levels provided better feature discrimination.

Guideline-Based Recommendations

Diagnosis

  • Utilize automated deep learning models to assist in histopathological diagnosis.

Management

  • Implement patient-aware evaluation protocols to avoid data leakage.

Monitoring & Follow-up

  • Regularly assess model performance using standardized metrics.

Risks

  • Be cautious of over-optimistic performance estimates due to data leakage.

Patient & Prescribing Data

Patients diagnosed with breast cancer requiring histopathological evaluation.

Automated systems can enhance diagnostic efficiency and consistency.

Clinical Best Practices

  • Adopt rigorous benchmarking frameworks for model evaluation.
  • Ensure uniform training conditions across different model architectures.
  • Focus on reproducibility in model performance assessments.

References

Original Source(s)

Related Content